MET and lung adenocarcinoma: In addition, Hsieb et al found lung adenocarcinoma with sarcomatoid transformation after EGFR‐TKI treatment and chemotherapy and six patients demonstrated giant cell features with aberrant MET activation and PD‐L1 expression after EGFR‐TKI treatment.18